Stone David, Banerjee Mousumi, Dupuis Joanne, Leleszi Jimmie, Allasio David, Singh Tajinder P
Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Pediatr Transplant. 2006 Aug;10(5):602-7. doi: 10.1111/j.1399-3046.2006.00543.x.
Because parents assume the primary responsibility for providing ambulatory post-transplant care to pediatric patients, pretransplant psychosocial evaluation in these recipients is usually focused on parents rather than on patients themselves. We sought to determine whether pretransplant parental psychosocial evaluation predicts post-transplant medical outcome at current levels of psychosocial support. We compared relative risk (RR) of rejection and hospitalizations (days of all-cause hospitalization) following initial discharge in patients in 'risk' and 'control' groups defined by their pretransplant parental psychosocial evaluation. We also compared the two groups of patients for the proportion of all outpatient trough cyclosporine A (CSA) or tacrolimus (FK) levels that were < 50% of the target level (defined as the mid-therapeutic range level). There were seven patients in the 'risk' group with a median age 0.25 yr (range 0.19-14.7 yr) and total follow up 20.5 patient-yr. There were 21 patients in the 'control' groups with a median age of 2.1 yr (range 0.05-16.2 yr) and total follow up of 71.3 patient-yr. There was no significant difference between the groups in rejection-risk or days of all-cause hospitalization early after transplant (first six months). During the late period (after the first six months), there were 11 rejection episodes in the 'risk' group over 17.4 patient-yr and four rejection episodes in control group over 61.8 patient-yr of follow up. After adjustment for age and race, patients in the 'risk' category had a RR of 3.4 for developing a rejection episode (p = 0.06) and 3.1 for being inpatient (p < 0.001) during the late period. Patients in the risk group were 2.9 times more likely to have subtherapeutic trough levels (< 50% target level) of calcineurin inhibitor (CSA or FK) during both early and late periods (p < 0.01 for both periods) after adjustment for patient age and race. We conclude that pretransplant parental psychosocial risk assessment is associated with post-transplant morbidity in children after cardiac transplantation. These patients may benefit from closer outpatient monitoring and a higher level of psychosocial support.
由于父母承担着为小儿患者提供门诊移植后护理的主要责任,这些受者移植前的心理社会评估通常侧重于父母而非患者自身。我们试图确定在当前心理社会支持水平下,移植前父母的心理社会评估能否预测移植后的医疗结果。我们比较了根据移植前父母心理社会评估定义的“风险”组和“对照组”患者初次出院后排斥反应和住院(全因住院天数)的相对风险(RR)。我们还比较了两组患者门诊全血谷浓度环孢素A(CSA)或他克莫司(FK)水平低于目标水平(定义为治疗范围中位数水平)50%的比例。“风险”组有7例患者,中位年龄0.25岁(范围0.19 - 14.7岁),总随访时间为20.5患者年。“对照组”有21例患者,中位年龄2.1岁(范围0.05 - 16.2岁),总随访时间为71.3患者年。两组在移植后早期(前六个月)的排斥反应风险或全因住院天数方面无显著差异。在后期(六个月后),“风险”组在17.4患者年中有11次排斥反应发作,对照组在61.8患者年的随访中有4次排斥反应发作。在对年龄和种族进行调整后,“风险”类别患者在后期发生排斥反应发作的RR为3.4(p = 0.06),住院的RR为3.1(p < 0.001)。在对患者年龄和种族进行调整后,“风险”组患者在早期和后期血药谷浓度低于治疗水平(< 50%目标水平)的钙调神经磷酸酶抑制剂(CSA或FK)的可能性是对照组的2.9倍(两个时期p均 < 0.01)。我们得出结论,移植前父母心理社会风险评估与心脏移植术后儿童的移植后发病率相关。这些患者可能受益于更密切的门诊监测和更高水平的心理社会支持。